Gross Profit - Cutia Therapeutics (HKEX:2487) - Alpha Spread
C

Cutia Therapeutics
HKEX:2487

Watchlist Manager
Cutia Therapeutics
HKEX:2487
Watchlist
Price: 14.06 HKD -0.28% Market Closed
Market Cap: 4.3B HKD
Have any thoughts about
Cutia Therapeutics?
Write Note

Cutia Therapeutics
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cutia Therapeutics
Gross Profit Peer Comparison

Comparables:
6160
1801
9926
603392
300122

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
C
Cutia Therapeutics
HKEX:2487
Gross Profit
ÂĄ71m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Gross Profit
ÂĄ14.7B
CAGR 3-Years
108%
CAGR 5-Years
67%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Gross Profit
ÂĄ5.1B
CAGR 3-Years
14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
Gross Profit
ÂĄ4.4B
CAGR 3-Years
N/A
CAGR 5-Years
335%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Gross Profit
ÂĄ4.5B
CAGR 3-Years
34%
CAGR 5-Years
45%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Gross Profit
ÂĄ11.7B
CAGR 3-Years
3%
CAGR 5-Years
26%
CAGR 10-Years
38%

See Also

What is Cutia Therapeutics's Gross Profit?
Gross Profit
71m CNY

Based on the financial report for Dec 31, 2023, Cutia Therapeutics's Gross Profit amounts to 71m CNY.

What is Cutia Therapeutics's Gross Profit growth rate?
Gross Profit CAGR 1Y
794%

Over the last year, the Gross Profit growth was 794%.

Back to Top